Clinical Trial Update: Ocular Surface Metabolo-lipidomics in Lateral Amyotrophic Sclerosis [NA]

View source ↗

Summary

A completed clinical trial evaluating ocular surface metabolo-lipidomics in individuals with amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: University Hospital, Tours | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: COMPLETED